SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gufic Biosciences surges on incorporating wholly owned subsidiary company

17 Mar 2022 Evaluate

Gufic Biosciences is currently trading at Rs. 242.85, up by 5.85 points or 2.47% from its previous closing of Rs. 237.00 on the BSE.

The scrip opened at Rs. 244.00 and has touched a high and low of Rs. 247.35 and Rs. 242.20 respectively. So far 14401 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 270.10 on 17-Jan-2022 and a 52 week low of Rs. 99.10 on 25-Mar-2021.

Last one week high and low of the scrip stood at Rs. 247.35 and Rs. 226.55 respectively. The current market cap of the company is Rs. 2355.27 crore.

The promoters holding in the company stood at 75.48%, while Institutions and Non-Institutions held 2.88% and 21.64% respectively.

Gufic Biosciences has incorporated wholly owned subsidiary company namely ‘Gufic UK’. Gufic UK is incorporated on March 15, 2022 and is yet to commence its business operation. Cost of acquisition is 1000 Pounds (1000 equity shares of 1 Pound each). Gufic UK is incorporated with the object to expand its pharmaceutical business in United Kingdom.

Gufic Biosciences is engaged in diversified business viz. Pharma, Healthcare, Bio- Technology, Seeds, Herbal etc.


Gufic Biosciences Share Price

297.10 -0.05 (-0.02%)
24-Apr-2026 15:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.00
Dr. Reddys Lab 1315.45
Cipla 1293.85
Zydus Lifesciences 926.45
Lupin 2297.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×